D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Broadcom
AVGO
|
+$596M |
| 2 |
Accenture
ACN
|
+$470M |
| 3 |
Intel
INTC
|
+$412M |
| 4 |
Adobe
ADBE
|
+$365M |
| 5 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$258M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$1.5B |
| 2 |
Apple
AAPL
|
+$1.02B |
| 3 |
Microsoft
MSFT
|
+$776M |
| 4 |
Netflix
NFLX
|
+$688M |
| 5 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$542M |
Sector Composition
| 1 | Technology | 26.84% |
| 2 | Consumer Discretionary | 15.19% |
| 3 | Financials | 10.39% |
| 4 | Healthcare | 9.6% |
| 5 | Industrials | 6.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1226
MarineMax
HZO
$556M
| $4.36M | ﹤0.01% |
134,837
+87,759
| +186% | +$2.84M |
|
|
LCW
1227
DELISTED
Learn CW Investment Corporation Class A Ordinary Shares
LCW
| $4.36M | ﹤0.01% |
400,200
| – | – |
|
1228
SpartanNash
SPTN
$897M
| $4.35M | ﹤0.01% |
232,125
-45,751
| -16% | -$858K |
|
1229
TriMas Corp
TRS
$1.59B
| $4.35M | ﹤0.01% |
170,253
-23,644
| -12% | -$604K |
|
1230
Burford Capital
BUR
$2.82B
| $4.35M | ﹤0.01% |
332,985
+147,557
| +80% | +$1.93M |
|
1231
Select Medical
SEM
$1.55B
| $4.34M | ﹤0.01% |
229,637
+25,245
| +12% | +$477K |
|
1232
Veritex Holdings
VBTX
$1.88B
| $4.34M | ﹤0.01% |
205,582
+23,469
| +13% | +$495K |
|
1233
Dolby
DLB
$6.85B
| $4.33M | ﹤0.01% |
54,589
+41,287
| +310% | +$3.27M |
|
1234
Enhabit
EHAB
$399M
| $4.32M | ﹤0.01% |
484,577
+75,915
| +19% | +$677K |
|
1235
Core Laboratories
CLB
$581M
| $4.32M | ﹤0.01% |
212,946
-31,260
| -13% | -$634K |
|
1236
Starwood Property Trust
STWD
$7.52B
| $4.31M | ﹤0.01% |
227,389
-70,247
| -24% | -$1.33M |
|
1237
Vanguard Small-Cap ETF
VB
$67.2B
| $4.3M | ﹤0.01% |
+19,726
| New | +$4.3M |
|
1238
The Greenbrier Companies
GBX
$1.42B
| $4.3M | ﹤0.01% |
86,780
-3,163
| -4% | -$157K |
|
1239
Universal Insurance Holdings
UVE
$719M
| $4.3M | ﹤0.01% |
229,103
+10,444
| +5% | +$196K |
|
1240
AnaptysBio
ANAB
$655M
| $4.3M | ﹤0.01% |
171,450
-15,354
| -8% | -$385K |
|
1241
KeyCorp
KEY
$20.9B
| $4.3M | ﹤0.01% |
302,337
-27,958
| -8% | -$397K |
|
|
RENE
1242
DELISTED
Cartesian Growth Corp II
RENE
| $4.29M | ﹤0.01% |
380,000
| – | – |
|
1243
Zscaler
ZS
$44.1B
| $4.28M | ﹤0.01% |
22,253
-575,420
| -96% | -$111M |
|
1244
Hewlett Packard
HPE
$32.6B
| $4.27M | ﹤0.01% |
201,853
-4,881,979
| -96% | -$103M |
|
1245
TG Therapeutics
TGTX
$5.1B
| $4.27M | ﹤0.01% |
240,012
+150,410
| +168% | +$2.68M |
|
1246
Invesco S&P MidCap Quality ETF
XMHQ
$5.11B
| $4.27M | ﹤0.01% |
+43,999
| New | +$4.27M |
|
1247
Bristow Group
VTOL
$1.09B
| $4.26M | ﹤0.01% |
127,098
+22,472
| +21% | +$753K |
|
1248
REV Group
REVG
$3.02B
| $4.23M | ﹤0.01% |
170,125
-130,386
| -43% | -$3.25M |
|
1249
Viavi Solutions
VIAV
$2.69B
| $4.23M | ﹤0.01% |
615,495
+32,479
| +6% | +$223K |
|
1250
Evergy
EVRG
$16.7B
| $4.23M | ﹤0.01% |
79,776
-410,225
| -84% | -$21.7M |
|